Health Canada

RSS

Marketing applications for volanesorsen accepted in U.S., E.U. and Canada

Nov. 16, 2017

Health Canada gives priority review status to ProMetic's NDS for Ryplazim

Oct. 20, 2017

Health Canada first to approve Shingrix

Oct. 16, 2017

Health Canada approves Maviret for chronic HCV in all major genotypes

Aug. 18, 2017

Gilead Sciences Canada receives approval notice for Vosevi in refractory HCV

Aug. 18, 2017

Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease

May 30, 2017

ViaCyte cleared to begin trial of PEC-Direct in U.S. and Canada

May 23, 2017

Health Canada approves Roche's cobas EGFR Mutation Test v2

March 16, 2017

Canada first to approve Kevzara

Feb. 1, 2017

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

June 27, 2016